Tears Naturale PM

Drug Overview

In the specialized field of Ophthalmology, managing severe dry eye requires around-the-clock protection. Tears Naturale PM is a highly trusted medication within the Ocular Lubricant drug class. For patients dealing with the severe discomfort, burning, and blurry vision associated with waking up with painfully dry eyes, finding a reliable overnight treatment is essential.

Unlike daytime liquid drops that wash away quickly, this formulation acts as a Targeted Therapy while the patient sleeps. It provides a thick, occlusive barrier that replaces missing moisture, soothes cellular damage, and protects the delicate outer layers of the cornea from environmental stress throughout the night. Because ointments lack water, this formulation is inherently Preservative-Free.

• Generic Name: White Petrolatum and Mineral Oil
• US Brand Names: Tears Naturale PM
• Route of Administration: Topical Ophthalmic Ointment (applied directly into the lower eyelid pocket)
• FDA Approval Status: FDA-approved as an Over-The-Counter (OTC) ophthalmic medication for the temporary relief of burning and irritation due to dryness of the eye and as a protectant against further irritation.

What Is It and How Does It Work? (Mechanism of Action)

To understand how this Targeted Therapy works, it is important to understand the tear film. A healthy tear film consists of a mucous layer, a watery (aqueous) layer, and an outer oily (lipid) layer. The lipid layer is crucial because it prevents the watery tears from evaporating into the air. In severe Dry Eye Disease (DED), this lipid layer fails, leading to rapid evaporation, exposure of sensitive corneal nerve endings, and cellular death.

Tears Naturale PM works through intense physical occlusion. The active ingredients, white petrolatum and mineral oil, consist of long, non-polar hydrocarbon chains. When applied to the eye, these highly viscous compounds do not dissolve. Instead, they spread out to form a thick, impermeable, hydrophobic (water-repelling) barrier over the cornea and conjunctiva.

At a physiological level, this occlusive barrier acts as a heavy-duty artificial lipid layer. It forcibly locks in the eye’s natural aqueous tears, bringing the evaporation rate down to near zero during sleep. Furthermore, it physically cushions the cornea from the friction of the inner eyelids. This is vital for patients suffering from nocturnal lagophthalmos, a condition where the eyelids do not fully close during sleep, exposing the eye to drying room air.

FDA-Approved Clinical Indications

Primary Indication

The primary FDA-approved indication for Tears Naturale PM is to provide overnight relief of burning, irritation, and discomfort due to severe dryness of the eye.

Other Approved & Off-Label Uses

Ophthalmologists and eye care specialists frequently utilize this occlusive ointment for a variety of severe ocular surface conditions:

• Exposure Keratopathy (due to facial nerve palsy or incomplete blinking)
• Recurrent Corneal Erosions (RCE)
• Floppy Eyelid Syndrome
• Post-surgical protection (following eyelid surgery or corneal abrasions)
• Primary Ophthalmology Indications:
  • Stabilize the Tear Film: By mimicking the eye’s natural lipid layer, the ointment completely halts tear film evaporation during the prolonged sleeping hours.
  • Preserve Visual Acuity: By preventing the corneal epithelium from drying out, cracking, and scarring overnight, the ointment ensures that the optical surface remains smooth and clear for daytime vision.
  • Protect Against Mechanical Friction: Provides a thick lubricating cushion that prevents the eyelid from sticking to and tearing the delicate surface cells of the cornea upon waking.

Dosage and Administration Protocols

Because this ointment is highly viscous and intentionally blurs vision, it is designed strictly for nighttime use just before sleep.

Specific Instructions for Administration: Wash hands thoroughly before use. Gently pull down the lower eyelid to form a pocket and squeeze the ribbon of ointment directly into this space. Close the eye gently to allow the body heat to melt and spread the ointment. If using concurrent daytime drops (such as glaucoma medications), apply them at least 10 minutes prior; Tears Naturale PM must be the absolute last medication applied, as drops cannot penetrate its thick lipid barrier.

“Dosage must be individualized by a qualified healthcare professional.”

Clinical Efficacy and Research Results

Current clinical study data (2020-2026) reinforces the critical role of occlusive nighttime therapies in comprehensive dry eye management. In clinical trials evaluating patients with moderate to severe Dry Eye Disease, the addition of a nighttime petrolatum-based ointment significantly improved daytime clinical metrics compared to daytime drop use alone.

Patients utilizing overnight ointments exhibit a measurable reduction in morning Ocular Surface Disease Index (OSDI) scores, often improving by 15 to 20 points, indicating a vast reduction in morning pain and light sensitivity. Objective clinical measurements show improvements in corneal health; patients frequently demonstrate a 2- to 3-point reduction in corneal fluorescein staining scores (on the Oxford scale) after 4 to 8 weeks of consistent use. By ensuring the cornea does not desiccate overnight, this therapy is highly efficacious in preventing the micro-abrasions that lead to permanent corneal scarring.

Safety Profile and Side Effects

There is no “Black Box Warning” for Tears Naturale PM. Because it contains no active pharmacological agents and is Preservative-Free, it has an exceptionally high safety profile.

Common side effects (>10%)

• Severe Blurred Vision: The ointment immediately and significantly blurs vision. This is an expected physical effect, which is why it is used at bedtime.
• Sticky Eyelashes: The ointment can leave a greasy residue on the eyelids the following morning.
• Mild Morning Puffy Eyelids: Temporary swelling of the eyelid margins due to the heavy lipid presence.

Serious adverse events

• Microbial Keratitis: Extremely rare, but possible if the tip of the ointment tube becomes contaminated with bacteria and is applied to a scratched eye.
• Foreign Body Sensation: Rare hypersensitivity to trace components in the mineral oil base.

Management Strategies: Strict sterile administration techniques are mandatory. Ensure the tip of the tube never touches the eyeball, eyelashes, or fingers. Morning residue should be gently cleaned away with a warm, damp washcloth or dedicated lid scrubs.

Research Areas

Direct Clinical Connections: Current ophthalmology research highlights the importance of nocturnal lubrication in relation to goblet cell density. Goblet cells in the conjunctiva produce the vital mucin layer of the tear film. Studies suggest that by preventing the extreme desiccation that occurs overnight, occlusive ointments protect these goblet cells from cellular death.

Generalization: Between 2020 and 2026, research in ocular surface disease has increasingly emphasized the necessity of Preservative-Free formulations. Researchers are also exploring Novel Delivery Systems, such as sustained-release intraocular implants and lipid-based nano-emulsions, to continuously deliver moisture without the heavy blurring associated with traditional ointments.

Severe Disease & Surgical Integration: In critical care and ICU settings, research underscores the life-saving vision benefits of petrolatum ointments in sedated patients, preventing exposure keratopathy and infectious corneal ulcers.

Disclaimer: These studies regarding sustained-release intraocular implants and nano-emulsions are currently in the preclinical phase and are not yet applicable to practical or professional clinical scenarios.

Patient Management and Clinical Protocols

Pre-treatment Assessment

• Baseline Diagnostics: Measurement of Baseline Visual Acuity, Tonometry (IOP measurement) to rule out underlying conditions like glaucoma, and a detailed Slit-lamp exam with fluorescein dye to identify current corneal abrasions.
• Ocular Imaging: Anterior segment Optical Coherence Tomography (OCT) to evaluate the thickness of the tear film meniscus.
• Specialized Testing: Tear film break-up time (TBUT) and assessing for incomplete eyelid closure (nocturnal lagophthalmos).
• Screening: A thorough history of contact lens use or sleep apnea (as CPAP machine air leaks frequently cause severe nighttime dry eye).

Monitoring and Precautions

• Vigilance: Patients must be monitored to ensure the ointment is not masking symptoms of an infection. If the patient experiences a sudden increase in sharp pain or thick yellow discharge, they must seek immediate medical attention to rule out a corneal ulcer.
• Lifestyle: Eyelid hygiene is critical. Patients should use warm compresses in the morning to melt away ointment residue and stimulate natural oil glands (lid scrubs). For patients using CPAP machines, ensuring a proper, airtight mask seal is vital.

“Do’s and Don’ts” list

• DO wash your hands thoroughly before applying the ointment.
• DO apply this medication as the absolute last step before going to sleep.
• DO use a warm washcloth in the morning to gently wipe away any greasy residue.
• DON’T let the tip of the tube touch your eye, eyelashes, fingers, or any other surface.
• DON’T apply other liquid eye drops after applying this ointment.
• DON’T use this ointment while wearing contact lenses, as it will permanently cloud them.

Legal Disclaimer

The medical information provided in this comprehensive guide is for educational and informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Severe dry eye symptoms can occasionally mimic more serious, vision-threatening conditions. Always seek the advice of your ophthalmologist, optometrist, or other qualified healthcare provider regarding your specific eye health, and before starting, stopping, or changing any treatment regimen. Never disregard professional medical advice or delay seeking it because of information contained in this material.